Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care Pathway

NCT07575880 | Not Yet Recruiting

• 1 other identifier: P-2026/07
• Study Type: observational
• Target: 200
• Locations: 0 countries
• Sites: N/A

Brief Summary

Undiagnosed COPD represents a significant issue in terms of morbidity and mortality, as nearly 50% of smokers with chronic respiratory symptoms also experience impaired quality of life and acute events similar to COPD exacerbations. We aim to study the prevalence of airflow obstruction (AO) and PRISm (preserved ratio impaired spirometry) in the general population.

Conditions

Chronic Obstructive Lung Disease; Airflow Obstruction

Outcome Measures

Primary Outcomes (1)

• Prevalence of newly diagnosed airflow obstruction (AO) and PRISm (preserved ratio impaired spirometry) in the general population

  On the day of inclusion

Secondary Outcomes (4)

• Description of the clinical characteristics of patients with and without Airflow Obstruction / with and without PRISm

  At the day of inclusion

• Description of the population participating to the prevention campaing

  At the day of inclusion

• Description of the symptomatic versus asymptomatic participant

  At the day of inclution

• Evaluation of the number of patients diagnosed with airflow obstruction or Prism and who attend a consult with a medical doctor after the prevention campain

  At Month 6

Interventions

Spirometry DIAGNOSTIC_TEST

Spirometry to identify airflow obstruction and PRISm (Preserved ration impaired spirometry)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Population attending the "9 Mai Poumon 2026" prevention campaign

You may qualify if:

• Age ≥ 18 years
• Participating to the prevention campain "Mai Poumons 2026" on 09 Mai 2026

You may not qualify if:

• Contre-indication to perform a spirometry : hemoptysy, pneumothorax, myocardal infarction \<1month, thoracic anevrism, recent ophtalmologic, abdominal or thoracic surgery
• Unable to perform a spirometry (understanding, coordination)
• Patient under legal protection
• Patient pregnant or breasting
• Not affiliating to public healthcare
• Patient deprived of liberty

Sponsors & Collaborators

• Centre Hospitalier de la côte Basque: lead

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Spirometry

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Respiratory Function Tests; Diagnostic Techniques, Respiratory System; Diagnostic Techniques and Procedures; Diagnosis

Central Study Contacts

Séverine LABARRERE

CONTACT

+33559443828; slabarrere@ch-cotebasque.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr Marielle SABATINI

Study Record Dates

• First Submitted: May 4, 2026
• First Posted: May 8, 2026
• Study Start: May 9, 2026
• Primary Completion (Estimated): December 1, 2026
• Study Completion (Estimated): December 1, 2026
• Last Updated: May 8, 2026

Record last verified: 2026-05